Product details
CeraVe AM Facial Moisturising Lotion SPF30 with UV Protection and 3 essential Ceramides for Normal to Dry Skin 52ml
For normal to dry skin, discover the CeraVe AM Facial Moisturising Lotion SPF30 is a lightweight daily morning moisturiser, suitable for all skin tones & skin types. Enriched with SPF30 and 3 Essential Ceramides, this moisturising lotion offers broad spectrum protection against UVA/UVB rays, preserves moisture for up to 24 hours and helps restore skin barrier function. Also suitable for sensitive skin. Apply in the morning after using a CeraVe cleanser as part of your daily skincare routine for maximal moisturising benefits.
Developed with Dermatologists:
All CeraVe products have been Developed with Dermatologists.
94% of UK Dermatologists recommend CeraVe*
*Survey of 85 UK Consultant Dermatologists, July 2022
Active Ingredients:
This daily moisturiser contains 3 Essential Ceramides, Niacinamide and Hyaluronic Acid. Formulated with patented MVE Technology, this moisturiser delivers instant & long-lasting hydration.
Key Benefits:
- Protects against broad spectrum UVA/UVB rays with SPF30, in line with expert recommendation: “I recommend wearing factor 50 every day and a minimum of factor 30” (Dr Ifeoma Ejikeme, Skin Consultant) .
- Continuous hydration for up to 24 hours
- Clinically proven skin barrier protection^
- Lightweight formula, non-greasy or sticky
- Non-comedogenic.
- Allergy tested
- 89% agree product absorbs quickly^^
- 94% agree skin feels healthier^^
Suitable for
Suitable for all skin types and can be applied on the face daily
How to use
After cleansing, use pump applicator to dispense product onto fingertips, or directly onto skin. We recommend using two finger lengths worth for full coverage.
Apply liberally to face and neck in the morning.
Avoid contact with eyes. If contact occurs rinse thoroughly with water.
Hazards and Cautions
In case of contact with the eyes, rinse immediately and thoroughly.
Important info
Country of Origin: France
Reviews
There are no reviews yet.